How Can We Help?
< Back

Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]

References

  1. ^ a b "Testosterone/dutasteride". AdisInsight. Springer Nature Switzerland AG.



Categories
Table of Contents